APA (7th ed.) Citation

N, S., S, S., M, R., & A, R. (2019). Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats. Dove Medical Press.

Chicago Style (17th ed.) Citation

N, Samsu, Soeharto S, Rifai M, and Rudijanto A. Rosmarinic Acid Monotherapy Is Better than the Combination of Rosmarinic Acid and Telmisartan in Preventing Podocyte Detachment and Inhibiting the Progression of Diabetic Nephropathy in Rats. Dove Medical Press, 2019.

MLA (8th ed.) Citation

N, Samsu, et al. Rosmarinic Acid Monotherapy Is Better than the Combination of Rosmarinic Acid and Telmisartan in Preventing Podocyte Detachment and Inhibiting the Progression of Diabetic Nephropathy in Rats. Dove Medical Press, 2019.